pr-inside.com
Back
Print

Griffin Securities, Inc. Announces Investment Opinion on Clinical Data, Inc.



2009-06-22 16:00:04 -

Griffin Securities, Inc. updated research coverage on Clinical Data, Inc. (NasdaqGM: CLDA) with a BUY Rating and a 12-month price target of $38.00.

Griffin Securities, Inc. specializes in identifying small cap emerging growth investment opportunities. The firm is a member of the Financial Industry Regulatory Authority (FINRA Broker ID 43229) and the Securities Investor Protection Corporation.

For a copy of the report, including disclosures, contact.

Chrystyna Bedrij


Griffin Securities, Inc.

212-509-9500

www.griffinsecurities.com : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww ..



Griffin Securities, Inc.Chrystyna Bedrij, 212-509-9500 www.griffinsecurities.com : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww ..



Press release: www.pr-inside.com
Contact Information: email




Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.